Annual Cash & Cash Equivalents
$28.66 M
-$8.82 M-23.53%
31 December 2023
Summary:
Synaptogenix annual cash & cash equivalents is currently $28.66 million, with the most recent change of -$8.82 million (-23.53%) on 31 December 2023. During the last 3 years, it has risen by +$22.87 million (+394.58%). SNPX annual cash & cash equivalents is now -23.53% below its all-time high of $37.48 million, reached on 31 December 2022.SNPX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$19.63 M
-$5.35 M-21.42%
30 September 2024
Summary:
Synaptogenix quarterly cash and cash equivalents is currently $19.63 million, with the most recent change of -$5.35 million (-21.42%) on 30 September 2024. Over the past year, it has dropped by -$12.10 million (-38.14%). SNPX quarterly cash and cash equivalents is now -47.63% below its all-time high of $37.48 million, reached on 31 December 2022.SNPX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNPX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.5% | -38.1% |
| 3 y3 years | +394.6% | -37.3% |
| 5 y5 years | - | - |
SNPX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.5% | +394.6% | -47.6% | at low |
| 5 y | 5 years | -23.5% | +394.6% | -47.6% | +238.7% |
| alltime | all time | -23.5% | +394.6% | -47.6% | +238.7% |
Synaptogenix Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.63 M(-21.4%) |
| June 2024 | - | $24.98 M(-5.1%) |
| Mar 2024 | - | $26.33 M(-8.1%) |
| Dec 2023 | $28.66 M(-23.5%) | $28.66 M(-9.7%) |
| Sept 2023 | - | $31.73 M(-3.6%) |
| June 2023 | - | $32.90 M(-8.1%) |
| Mar 2023 | - | $35.78 M(-4.5%) |
| Dec 2022 | $37.48 M | $37.48 M(+42.3%) |
| Sept 2022 | - | $26.33 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $28.75 M(-8.1%) |
| Mar 2022 | - | $31.28 M(-8.6%) |
| Dec 2021 | $34.21 M(+490.4%) | $34.21 M(+9.3%) |
| Sept 2021 | - | $31.29 M(-1.3%) |
| June 2021 | - | $31.70 M(+113.5%) |
| Mar 2021 | - | $14.85 M(+156.2%) |
| Dec 2020 | $5.80 M(-66.7%) | $5.80 M(-78.5%) |
| Sept 2020 | - | $27.00 M(+55.3%) |
| Dec 2019 | $17.38 M | $17.38 M |
FAQ
- What is Synaptogenix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Synaptogenix?
- What is Synaptogenix annual cash & cash equivalents year-on-year change?
- What is Synaptogenix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Synaptogenix?
- What is Synaptogenix quarterly cash and cash equivalents year-on-year change?
What is Synaptogenix annual cash & cash equivalents?
The current annual cash & cash equivalents of SNPX is $28.66 M
What is the all time high annual cash & cash equivalents for Synaptogenix?
Synaptogenix all-time high annual cash & cash equivalents is $37.48 M
What is Synaptogenix annual cash & cash equivalents year-on-year change?
Over the past year, SNPX annual cash & cash equivalents has changed by -$8.82 M (-23.53%)
What is Synaptogenix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SNPX is $19.63 M
What is the all time high quarterly cash and cash equivalents for Synaptogenix?
Synaptogenix all-time high quarterly cash and cash equivalents is $37.48 M
What is Synaptogenix quarterly cash and cash equivalents year-on-year change?
Over the past year, SNPX quarterly cash and cash equivalents has changed by -$12.10 M (-38.14%)